[Overview of U.S. stock market pre-market news: Jen-Hsun Huang said there is little chance of a memory glut by 2029; Intel received a one-year robot import restriction exemption; SpaceX aims to use the rights to 80,000 base stations in the United States] On October 23, the financial news of the U.S. stock market that investors need to focus on is as follows: 1. The three major U.S. stock index futures collectively fell. Dow Jones futures fell 0.78%, S&P 500 futures fell 0.35%, and Nasdaq 100 futures fell 0.17%. 2. International oil prices both rose. WTI crude oil futures prices rose 1.87% to US$101.326/barrel; Brent crude oil futures prices rose 1.59% to US$114.964/barrel. 3. International gold and silver spot prices were mixed. Spot gold prices rose 0.12% to US$4,029.05 per ounce; spot silver prices fell by 1.36% to US$53.82 per ounce. 4. The three major European stock indexes fell across the board. Britain's FTSE 100 index fell 0.55%, France's CAC40 index fell 0.76%, and Germany's DAX30 index fell 0.94%. 5. Intel’s chief technology officer said that even with sufficient funds, global cutting-edge wafer production would be difficult to expand tenfold, and a more realistic upper limit of growth would be about twice. The key equipment, clean rooms and fab scale required to manufacture advanced chips are becoming a new production capacity ceiling. 6. Nvidia CEO Jensen Huang said on Thursday that the memory chip industry is unlikely to have a surplus by 2029. He pointed out, "One of the great things about memory is that you can always use more. HBM will continue to be widely adopted for several years." 7. The U.S. Federal Communications Commission (FCC) approved a one-year exemption for Intel on the 22nd local time, exempting it from import restrictions on some foreign-made advanced robotic equipment. 8. SpaceX plans to obtain the right to use at least 80,000 base stations in the United States and is negotiating with at least one large cellular infrastructure company. If the agreement is reached, SpaceX is expected to become the fourth national wireless operator in the United States. 9. Some clinical trial data of Intismeran autogene, a personalized cancer vaccine jointly developed by Moderna and Merck, were leaked in advance. Analysts believe the trial results are overall positive. 10. OpenAI financing negotiations are coming to an end, seeking approximately US$30 billion in financing, and the valuation target is reported to have been lowered to US$1.25 trillion. 11. Bank of America expects the market's risk aversion to continue until mid-November, and U.S. bond yields, U.S. stocks and the U.S. dollar may all fall.